0

Close
 
Upcoming Allied Market Research
2023
Pathology Market

Pathology Market

by Product (Scanners, Software, Communication Systems, Storage Systems, Instruments, Consumables, Services), by Type (Human Digital Pathology, Animal Digital Pathology), by Application (Disease Diagnosis, Teleconsultation, Drug Discovery Development, Training Education, Others) and by End User (Pharmaceutical, Biotechnology Companies, and CROs, Hospitals Reference Laboratories, Academic Government Research Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A03240
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pathology Market

Request Now !

Pathology is a branch of medical research that involves the study of the cause, origin, and nature of a disease by examining the body fluids, organ, and tissues. It determines the actual state of the disease to decide the course of treatment of different disease. There are basically of two types, namely digital and anatomical pathology.

Digital pathology involves the use of digitized glass slide for the interpretation of pathology information, while anatomical pathology involves the diagnosis of disease based on microscopic as well as macroscopic examination of organs, tissues, and body fluids. The global pathology market is anticipated to register significant growth during the forecast period due to the growing need for integrated healthcare facilities and growing prevalence of chronic conditions.

The global pathology market is driven by ease of transportation of slides, surge in prevalence of chronic diseases & aging population, and increase in the laboratory workflow efficiency. However, lack of reimbursement and dearth of skilled personnel restrict the market growth. Furthermore, unmet pathological needs in the emerging economies are expected to provide numerous opportunities for the market growth during the forecast period.

The global pathology market is segmented based on products, type, application, end user, and geography. Based on product, it is classified into scanners, software, communication systems, storage systems, instruments, consumables, and services. Based on type, it is divided into human pathology and animal pathology. On the basis of application, it is categorized into disease diagnosis, teleconsultation, drug discovery & development, training & education, and others.

Based on end user, it is divided into pharmaceutical, biotechnology companies, and CROs; hospitals & reference laboratories and academic & government research institutes. The market is analyzed across regions, namely, North America, Europe, Asia-Pacific, and LAMEA further country level analysis of regions is provided to determine the market size and forecast for each segment and sub-segment of the market in various countries across the globe.

The key players profiled in the report include Leica Biosystems Nussloch GMBH, GE Healthcare, Hamamatsu Photonics K.K, microDimensions GmbH, Mikroscan Technologies, Inc., Omnyx LLC., Koninklijke Philips N.V. Healthcare, Huron Digital Pathology Inc., Ventana Medical Systems, Inc., and Apollo Enterprise Imaging Corporation.

Key Benefits

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis of the industry to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis by product elucidates the use of pathological product in detecting cause, origin, and nature of diseases.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market.

 Pathology Market Report Highlights

Aspects Details
By Product
  • Scanners
  • Software
  • Communication Systems
  • Storage Systems
  • Instruments
  • Consumables
  • Services
By Type
  • Human Digital Pathology
  • Animal Digital Pathology
By Application
  • Disease Diagnosis
  • Teleconsultation
  • Drug Discovery & Development
  • Training & Education
  • Others
By End User
  • Pharmaceutical, Biotechnology Companies, and CROs
  • Hospitals & Reference Laboratories
  • Academic & Government Research Institutes
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Ventana Medical Systems, Inc., Leica Biosystems Nussloch GMBH, Huron Digital Pathology Inc., Omnyx LLC., microDimensions GmbH, Koninklijke Philips N.V., Mikroscan Technologies, Inc., Apollo Enterprise Imaging Corporation, Hamamatsu Photonics K.K, GE Healthcare
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: PATHOLOGY MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Scanners

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Software

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Communication Systems

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Storage Systems

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Instruments

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Consumables

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Services

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: PATHOLOGY MARKET, BY TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Type

    • 5.2. Human Digital Pathology

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Animal Digital Pathology

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: PATHOLOGY MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Disease Diagnosis

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Teleconsultation

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Drug Discovery Development

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Training Education

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: PATHOLOGY MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Pharmaceutical, Biotechnology Companies, And CROs

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Hospitals Reference Laboratories

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Academic Government Research Institutes

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: PATHOLOGY MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Type

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Pathology Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Type
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Pathology Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Type
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Pathology Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Type
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Type

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Pathology Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Type
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Pathology Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Type
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Pathology Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Type
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Pathology Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Type
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Pathology Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Type
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Pathology Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Type
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Pathology Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Type
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Type

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Pathology Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Type
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Pathology Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Type
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Pathology Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Type
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Pathology Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Type
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Pathology Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Type
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Pathology Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Type
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Pathology Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Type
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Pathology Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Type
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Pathology Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Type
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Type

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Pathology Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Type
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Pathology Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Type
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Pathology Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Type
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Pathology Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Type
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Pathology Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Type
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Pathology Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Type
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Leica Biosystems Nussloch GMBH

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. GE Healthcare

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Hamamatsu Photonics K.K

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. MicroDimensions GmbH

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Mikroscan Technologies, Inc.

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Omnyx LLC.

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Koninklijke Philips N.V.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Huron Digital Pathology Inc.

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Ventana Medical Systems, Inc.

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Apollo Enterprise Imaging Corporation

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PATHOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL PATHOLOGY MARKET FOR SCANNERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL PATHOLOGY MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL PATHOLOGY MARKET FOR COMMUNICATION SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL PATHOLOGY MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL PATHOLOGY MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL PATHOLOGY MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL PATHOLOGY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL PATHOLOGY MARKET FOR HUMAN DIGITAL PATHOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL PATHOLOGY MARKET FOR ANIMAL DIGITAL PATHOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL PATHOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL PATHOLOGY MARKET FOR TELECONSULTATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL PATHOLOGY MARKET FOR DRUG DISCOVERY DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL PATHOLOGY MARKET FOR TRAINING EDUCATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL PATHOLOGY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL PATHOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL PATHOLOGY MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY COMPANIES, AND CROS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL PATHOLOGY MARKET FOR HOSPITALS REFERENCE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL PATHOLOGY MARKET FOR ACADEMIC GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL PATHOLOGY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA PATHOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. U.S. PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. U.S. PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. U.S. PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. U.S. PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. CANADA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. CANADA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. CANADA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. CANADA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE PATHOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. ITALY PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. ITALY PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 55. ITALY PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. ITALY PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. SPAIN PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. UK PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. UK PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. UK PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. UK PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 67. RUSSIA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. RUSSIA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. REST OF EUROPE PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. REST OF EUROPE PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC PATHOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 76. ASIA-PACIFIC PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. ASIA-PACIFIC PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. CHINA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. CHINA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. CHINA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. CHINA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. JAPAN PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. JAPAN PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. INDIA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. INDIA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. INDIA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. INDIA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH KOREA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH KOREA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 96. AUSTRALIA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. AUSTRALIA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. THAILAND PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. THAILAND PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 104. MALAYSIA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 105. MALAYSIA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 108. INDONESIA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 109. INDONESIA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 112. REST OF ASIA PACIFIC PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 113. REST OF ASIA PACIFIC PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA PATHOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 117. LAMEA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 118. LAMEA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 121. BRAZIL PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 122. BRAZIL PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 125. SOUTH AFRICA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 126. SOUTH AFRICA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 129. SAUDI ARABIA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 130. SAUDI ARABIA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 131. UAE PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 132. UAE PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 133. UAE PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 134. UAE PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 137. ARGENTINA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 138. ARGENTINA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA PATHOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA PATHOLOGY, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 141. REST OF LAMEA PATHOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 142. REST OF LAMEA PATHOLOGY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 143. LEICA BIOSYSTEMS NUSSLOCH GMBH: KEY EXECUTIVES
  • TABLE 144. LEICA BIOSYSTEMS NUSSLOCH GMBH: COMPANY SNAPSHOT
  • TABLE 145. LEICA BIOSYSTEMS NUSSLOCH GMBH: OPERATING SEGMENTS
  • TABLE 146. LEICA BIOSYSTEMS NUSSLOCH GMBH: PRODUCT PORTFOLIO
  • TABLE 147. LEICA BIOSYSTEMS NUSSLOCH GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 149. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 150. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 151. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 152. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. HAMAMATSU PHOTONICS K.K: KEY EXECUTIVES
  • TABLE 154. HAMAMATSU PHOTONICS K.K: COMPANY SNAPSHOT
  • TABLE 155. HAMAMATSU PHOTONICS K.K: OPERATING SEGMENTS
  • TABLE 156. HAMAMATSU PHOTONICS K.K: PRODUCT PORTFOLIO
  • TABLE 157. HAMAMATSU PHOTONICS K.K: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. MICRODIMENSIONS GMBH: KEY EXECUTIVES
  • TABLE 159. MICRODIMENSIONS GMBH: COMPANY SNAPSHOT
  • TABLE 160. MICRODIMENSIONS GMBH: OPERATING SEGMENTS
  • TABLE 161. MICRODIMENSIONS GMBH: PRODUCT PORTFOLIO
  • TABLE 162. MICRODIMENSIONS GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 163. MIKROSCAN TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 164. MIKROSCAN TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 165. MIKROSCAN TECHNOLOGIES, INC.: OPERATING SEGMENTS
  • TABLE 166. MIKROSCAN TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 167. MIKROSCAN TECHNOLOGIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 168. OMNYX LLC.: KEY EXECUTIVES
  • TABLE 169. OMNYX LLC.: COMPANY SNAPSHOT
  • TABLE 170. OMNYX LLC.: OPERATING SEGMENTS
  • TABLE 171. OMNYX LLC.: PRODUCT PORTFOLIO
  • TABLE 172. OMNYX LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 173. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 174. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 175. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
  • TABLE 176. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 177. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 178. HURON DIGITAL PATHOLOGY INC.: KEY EXECUTIVES
  • TABLE 179. HURON DIGITAL PATHOLOGY INC.: COMPANY SNAPSHOT
  • TABLE 180. HURON DIGITAL PATHOLOGY INC.: OPERATING SEGMENTS
  • TABLE 181. HURON DIGITAL PATHOLOGY INC.: PRODUCT PORTFOLIO
  • TABLE 182. HURON DIGITAL PATHOLOGY INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 183. VENTANA MEDICAL SYSTEMS, INC.: KEY EXECUTIVES
  • TABLE 184. VENTANA MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
  • TABLE 185. VENTANA MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
  • TABLE 186. VENTANA MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
  • TABLE 187. VENTANA MEDICAL SYSTEMS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 188. APOLLO ENTERPRISE IMAGING CORPORATION: KEY EXECUTIVES
  • TABLE 189. APOLLO ENTERPRISE IMAGING CORPORATION: COMPANY SNAPSHOT
  • TABLE 190. APOLLO ENTERPRISE IMAGING CORPORATION: OPERATING SEGMENTS
  • TABLE 191. APOLLO ENTERPRISE IMAGING CORPORATION: PRODUCT PORTFOLIO
  • TABLE 192. APOLLO ENTERPRISE IMAGING CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PATHOLOGY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PATHOLOGY MARKET
  • FIGURE 3. SEGMENTATION PATHOLOGY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PATHOLOGY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPATHOLOGY MARKET
  • FIGURE 11. PATHOLOGY MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. PATHOLOGY MARKET FOR SCANNERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. PATHOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. PATHOLOGY MARKET FOR COMMUNICATION SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. PATHOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. PATHOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. PATHOLOGY MARKET FOR SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. PATHOLOGY MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 20. PATHOLOGY MARKET FOR HUMAN DIGITAL PATHOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. PATHOLOGY MARKET FOR ANIMAL DIGITAL PATHOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. PATHOLOGY MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 23. PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. PATHOLOGY MARKET FOR DRUG DISCOVERY DEVELOPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. PATHOLOGY MARKET FOR TRAINING EDUCATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. PATHOLOGY MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. PATHOLOGY MARKET SEGMENTATION, BY BY END USER
  • FIGURE 29. PATHOLOGY MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY COMPANIES, AND CROS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. PATHOLOGY MARKET FOR HOSPITALS REFERENCE LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. PATHOLOGY MARKET FOR ACADEMIC GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: PATHOLOGY MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. LEICA BIOSYSTEMS NUSSLOCH GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. LEICA BIOSYSTEMS NUSSLOCH GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. LEICA BIOSYSTEMS NUSSLOCH GMBH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. GE HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. HAMAMATSU PHOTONICS K.K: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. HAMAMATSU PHOTONICS K.K: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. HAMAMATSU PHOTONICS K.K: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. MICRODIMENSIONS GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MICRODIMENSIONS GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. MICRODIMENSIONS GMBH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. MIKROSCAN TECHNOLOGIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. MIKROSCAN TECHNOLOGIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. MIKROSCAN TECHNOLOGIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. OMNYX LLC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. OMNYX LLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. OMNYX LLC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. HURON DIGITAL PATHOLOGY INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. HURON DIGITAL PATHOLOGY INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. HURON DIGITAL PATHOLOGY INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. VENTANA MEDICAL SYSTEMS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. VENTANA MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. VENTANA MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. APOLLO ENTERPRISE IMAGING CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. APOLLO ENTERPRISE IMAGING CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. APOLLO ENTERPRISE IMAGING CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Pathology Market

Start reading.
This Report and over 66,782+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers